(Q38115166)

29 August 2017

Mitosis as an anti-cancer drug target (English)

1 reference

29 August 2017

Anna-Leena Salmela

1

1 reference

PubMed ID

23775312

29 August 2017

Marko J Kallio

series ordinal

2

1 reference

29 August 2017

18 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

122

1 reference

29 August 2017

5

1 reference

29 August 2017

431-449

1 reference

https://scigraph.springernature.com/pub.10.1007/s00412-013-0419-8

29 August 2017

0 references

cites work

Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint.

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mutational analysis of TTK gene in gastric and colorectal cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Histone deacetylation : an attractive target for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Biological effects and mechanism of action of farnesyl transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The cellular geography of aurora kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora kinases: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mitosis-targeted anti-cancer therapies: where they stand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The conserved KMN network constitutes the core microtubule-binding site of the kinetochore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Rho-stimulated contractility drives the formation of stress fibers and focal adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Human cancer cells commonly acquire DNA damage during mitotic arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Survival of aneuploid, micronucleated and/or polyploid cells: crosstalk between ploidy control and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

HDAC modulation and cell death in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Kinetochore microtubule dynamics and attachment stability are regulated by Hec1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Probing CENP-E function in chromosome dynamics using small molecule inhibitor syntelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A small-molecule inhibitor of Mps1 blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Short and long-term tumor cell responses to Aurora kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Histone deacetylase inhibitors and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation relieves autoinhibition of the kinetochore motor Cenp-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Defining the chemotherapeutic targets of histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Limiting the proliferation of polyploid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Crystallization and preliminary crystallographic analysis of the motor domain of human kinetochore-associated protein CENP-E using an automated crystallization procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

How do anti-mitotic drugs kill cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Is the focus moving toward a combination of targeted drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

CENP-E--dependent BubR1 autophosphorylation enhances chromosome alignment and the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

RNA interference against Hec1 inhibits tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Farnesyltransferase inihibitors in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Risks of leukaemia and solid tumours in individuals with Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

UA62784, a novel inhibitor of centromere protein E kinesin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Losing balance: the origin and impact of aneuploidy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

ENMD-2076 for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation sites in BubR1 that regulate kinetochore attachment, tension, and mitotic exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

TTK/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosome segregation and cancer: cutting through the mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mitosis as an anti-cancer target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability by inefficient Mps1 auto-activation due to a weakened mitotic checkpoint and lagging chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Overexpression and amplification of Aurora-A in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomes can congress to the metaphase plate before biorientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora kinases and protein phosphatase 1 mediate chromosome congression through regulation of CENP-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

On the road to cancer: aneuploidy and the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Centrosome clustering and chromosomal (in)stability: a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Improved grading of breast adenocarcinomas based on genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Selective Aurora Kinase Inhibitors Identified Using a Taxol-Induced Checkpoint Sensitivity Screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A chemical tool box defines mitotic and interphase roles for Mps1 kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability confers intrinsic multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Farnesyl transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Hec1 sequentially recruits Zwint-1 and ZW10 to kinetochores for faithful chromosome segregation and spindle checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Small-molecule and mutational analysis of allosteric Eg5 inhibition by monastrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Killing cells by targeting mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

G1 tetraploidy checkpoint and the suppression of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora-A - a guardian of poles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Spindle poisons and cell fate: a tale of two pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The highly conserved Ndc80 complex is required for kinetochore assembly, chromosome congression, and spindle checkpoint activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

PLK1 as an oncology target: current status and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Progress in the discovery of polo-like kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The proliferation rate paradox in antimitotic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The spindle-assembly checkpoint in space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Novel ATP-competitive kinesin spindle protein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mechanisms of drug-induced mitotic catastrophe in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Activity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Synthesis and biological evaluation of a series of novel inhibitor of Nek2/Hec1 analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mitotic drug targets and the development of novel anti-mitotic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Ablation of the spindle assembly checkpoint by a compound targeting Mps1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability determines taxane response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Polo-like kinases (Plks) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Identification of aneuploidy-selective antiproliferation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Gene silencing of CENP-E by small interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The mitotic checkpoint in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Examining the link between chromosomal instability and aneuploidy in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mps1 kinase activity restrains anaphase during an unperturbed mitosis and targets Mad2 to kinetochores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The Ndc80 complex: integrating the kinetochore's many movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The Ndc80 complex uses a tripartite attachment point to couple microtubule depolymerization to chromosome movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The chromosomal passenger complex: guiding Aurora-B through mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal passengers: the four-dimensional regulation of mitotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Plasma membrane alterations and cytoskeletal changes in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Structural and mechanistic insights into Mps1 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Deficiency in chromosome congression by the inhibition of Plk1 polo box domain-dependent recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aneuploidy: instigator and inhibitor of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

The aneuploidy paradox in cell growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aneuploidy acts both oncogenically and as a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Phosphorylation of the Ndc80 complex protein, HEC1, by Nek2 kinase modulates chromosome alignment and signaling of the spindle assembly checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Centromere-associated protein E: a motor that puts the brakes on the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Spindle checkpoint function and cellular sensitivity to antimitotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

CENP-E is a putative kinetochore motor that accumulates just before mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Taxol suppresses dynamics of individual microtubules in living human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Getting down to the phosphorylated 'nuts and bolts' of spindle checkpoint signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00412-013-0419-8

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

21 January 2018

1 reference

12 December 2020

Aurora kinase inhibitors: progress towards the clinic

1 reference

12 December 2020

Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity

1 reference

12 December 2020

The Aurora kinase family in cell division and cancer.

1 reference

12 December 2020

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

1 reference

12 December 2020

hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation

1 reference

12 December 2020

Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis

1 reference

12 December 2020

Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.

1 reference

12 December 2020

Novel pyrimidine-2,4-diamine derivative suppresses the cell viability and spindle assembly checkpoint activity by targeting Aurora kinases

1 reference

12 December 2020

Mitotic drivers--inhibitors of the Aurora B Kinase

1 reference

12 December 2020

Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells

1 reference

12 December 2020

Histone deacetylase inhibitors induce mitotic slippage

1 reference

12 December 2020

Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis

1 reference

12 December 2020

MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation

1 reference

12 December 2020

Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy

1 reference

12 December 2020

Mitotic kinase expression and colorectal cancer progression

1 reference

12 December 2020

Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice

1 reference

12 December 2020

Aneuploidy and cancer

1 reference

12 December 2020

When 2+2=5: the origins and fates of aneuploid and tetraploid cells

1 reference

12 December 2020

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

1 reference

12 December 2020

Bleb formation and F-actin distribution during mitosis and tumor necrosis factor-induced apoptosis

1 reference

12 December 2020

Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency

1 reference

12 December 2020

Causes and consequences of aneuploidy in cancer.

1 reference

12 December 2020

Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.

1 reference

12 December 2020

Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis

1 reference

12 December 2020

R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways

1 reference

12 December 2020

Kinesin motor proteins as targets for cancer therapy

1 reference

12 December 2020

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study

1 reference

12 December 2020

Preventing aneuploidy: the contribution of mitotic checkpoint proteins.

1 reference

12 December 2020

Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability.

1 reference

12 December 2020

10.1007/S00412-013-0419-8

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23775312